- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Osteoporosis
- Meeting Date: July 2022
- Public Summary Document (PSD) July 2022 PBAC Meeting - (PDF 1.1MB)
- Public Summary Document (PSD) July 2022 PBAC Meeting - (Word 280KB)
Romosozumab – July 2022
Romosozumab: Injection 105 mg in 1.17 mL single use pre-filled syringe; Evenity®
Last updated
28 October 2022